TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 7,931,116 | $140,381,000 | 32.92% |
Endurant Capital Management LP | 932,967 | $16,514,000 | 6.51% |
Glenview Capital Management | 26,430,828 | $467,826,000 | 4.24% |
Paulson & Co. | 13,244,711 | $234,431,000 | 3.98% |
Blackcrane Capital, LLC | 172,955 | $3,061,000 | 3.88% |
NINE MASTS CAPITAL Ltd | 1,474,286 | $26,146,000 | 3.74% |
Velanne Asset Management Ltd | 286,640 | $5,074,000 | 3.22% |
LMR Partners LLP | 4,563,591 | $80,884,000 | 2.95% |
SECTOR GAMMA AS | 796,299 | $14,094,000 | 2.26% |
MFN Partners Management, LP | 785,000 | $13,895,000 | 2.21% |